Modulated Guanidine Polymers for siRNA Delivery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for delivering siRNA to ovarian cancer cells face challenges such as multidrug resistance, poor intracellular entry, and inefficient targeting due to enzymatic degradation and cellular membrane penetration issues, particularly in the presence of mucus layers in the airway epithelium, leading to suboptimal therapeutic outcomes.
Innovation Solution
Development of biodegradable aromatic π-electron conjugated polymers (CPs) with guanidine units, modulated with functional groups like aminoethoxyethanol and morpholine, which form nanoparticles that efficiently penetrate cancer cells and enhance siRNA delivery by optimizing cellular entry and localization, overcoming the limitations of conventional delivery methods.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional lipid-based or positively charged carriers are used to deliver siRNA, then transfection efficiency is improved, but delivery through mucus layers is blocked
Solution Approach 1:
The invention changes the charge parameter of the carrier from positive to negative by using poly(sialic acid) and poly(aspartic acid) blocks. This parameter change allows the carrier to pass through the negatively charged mucus layer without being trapped, while still achieving efficient transfection of the target cells.
Solution Approach 2:
The invention uses a block copolymer composite structure combining poly(sialic acid) or poly(aspartic acid) blocks with poly(ethylene glycol) blocks. This composite material provides both mucus-penetrating capability (via the negatively charged blocks) and cellular delivery efficiency (via the PEG block), resolving the contradiction between mucus penetration and transfection efficiency.
2Reliability
If high millimolar concentrations of mucus-altering agents are used to disrupt mucus layers, then carrier delivery is improved, but cellular toxicity increases
Solution Approach 1:
The invention changes the charge parameter of the carrier from positive to negative, eliminating the need for high concentrations of mucus-altering agents. This parameter change enables mucus penetration at physiological concentrations, avoiding the cellular toxicity associated with high doses of mucolytic agents.
Solution Approach 2:
The negatively charged polymer blocks act as an intermediary that facilitates carrier passage through the mucus layer without requiring external mucus-disrupting agents. This intermediary mechanism avoids the toxic side effects of high-concentration mucolytics while maintaining effective delivery.
3Speed
If PEG block is added to shield positive charge, then diffusion through mucus is improved, but gene complexation and cellular entry are reduced
Solution Approach 1:
The invention inverts the conventional approach by making the mucus-interacting blocks negatively charged instead of positive. This inversion allows the PEG blocks to maintain their hydrodynamic shielding function while the charged blocks provide both mucus penetration and gene complexation capabilities, eliminating the trade-off present in cationic PEGylated systems.
4Measurement precision
If endocytosis mediated by cell surface receptors is used for entry, then targeting is improved, but intracellular availability is reduced due to degradation
Solution Approach 1:
The invention performs preliminary action by enabling direct membrane translocation before endocytosis occurs. The negatively charged polymer allows the siRNA complex to cross the plasma membrane directly, avoiding subsequent endosomal trapping and degradation, thereby maintaining high intracellular availability while preserving targeting capability.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The modulated CPs achieve significant siRNA delivery and gene knockdown efficiency, increasing drug potency and reducing the need for high doses, while maintaining biocompatibility and avoiding cell viability inhibition, thus enhancing chemotherapy efficacy against cancer cells.
Implementation Method 1
Combination of ionic bonding, hydrogen bonding, and hydrophobic interactions influence the entry pathways
Implementation Method 2
Combination of ionic bonding, hydrogen bonding, and hydrophobic interactions influence the entry pathways
Implementation Method 3
Combination of ionic bonding, hydrogen bonding, and hydrophobic interactions influence the entry pathways
Data Source
AI summary
A modulated guanidine substituted polymer or nanoparticle has a guanidine moiety or on a plurality of repeating units of a polymer or on the surface of a nanoparticle where the guanidine moiety is modulated as a substituted amidinourea or amidinocarbamate or salt thereof. The modulated guanidine substituted polymer or nanoparticle can be prepared by direct amination of a N-Boc protected guanidine substituted conjugated polymer or N-Boc protected guanidine substituted nanoparticle, where an amine or alcohol is combined in solution or suspension with the protected conjugated polymer or nanoparticle and the resulting mixture is heated. The modulated guanidine substituted polymer or nanoparticle can be used in a cancer treatment formulation.